These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28447484)

  • 1. Assessment of pain during medical abortion with home use of misoprostol.
    Cavet S; Fiala C; Scemama A; Partouche H
    Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):207-211. PubMed ID: 28447484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain during medical abortion in early pregnancy in teenage and adult women.
    Kemppainen V; Mentula M; Palkama V; Heikinheimo O
    Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1603-1610. PubMed ID: 32441319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.
    Avraham S; Gat I; Duvdevani NR; Haas J; Frenkel Y; Seidman DS
    Fertil Steril; 2012 Mar; 97(3):612-5. PubMed ID: 22265034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain during medical abortion: a multicenter study in France.
    Saurel-Cubizolles MJ; Opatowski M; David P; Bardy F; Dunbavand A
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():212-7. PubMed ID: 26448133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion.
    Ravn P; Rasmussen A; Knudsen UB; Kristiansen FV
    Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1098-102. PubMed ID: 16232179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
    Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
    Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA; Stadalius LS; Eisinger SH; Franks P
    J Fam Pract; 1997 Apr; 44(4):353-60. PubMed ID: 9108832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion.
    Kopp Kallner H; Fiala C; Gemzell-Danielsson K
    Contraception; 2012 Apr; 85(4):394-7. PubMed ID: 22067756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding a woman's options to include home use of misoprostol for medical abortion up until 76 days: an observational study of efficacy and safety.
    Larsson A; Ronnberg AM
    Acta Obstet Gynecol Scand; 2019 Jun; 98(6):747-752. PubMed ID: 30659579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K; Pekhlivanov B; Amaliev I
    Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain during medical abortion: predicting factors from gynecologic history and medical staff evaluation of severity.
    Suhonen S; Tikka M; Kivinen S; Kauppila T
    Contraception; 2011 Apr; 83(4):357-61. PubMed ID: 21397095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol administration in medical abortion. A comparison of three regimens.
    Wiebe ER
    J Reprod Med; 2001 Feb; 46(2):125-9. PubMed ID: 11255811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.